UBS Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56M | Sell |
445,684
-200,463
| -31% | -$25.2M | 0.01% | 1119 |
|
|
2025
Q1 | $88.4M | Sell |
646,147
-402,272
| -38% | -$55M | 0.02% | 801 |
|
|
2024
Q4 | $160M | Buy |
1,048,419
+544,566
| +108% | +$83.3M | 0.03% | 495 |
|
|
2024
Q3 | $97.7M | Buy |
503,853
+51,342
| +11% | +$9.95M | 0.02% | 537 |
|
|
2024
Q2 | $105M | Sell |
452,511
-23,315
| -5% | -$5.4M | 0.03% | 492 |
|
|
2024
Q1 | $103M | Buy |
475,826
+137,472
| +41% | +$29.6M | 0.03% | 475 |
|
|
2023
Q4 | $87.6M | Sell |
338,354
-81,444
| -19% | -$21.1M | 0.03% | 460 |
|
|
2023
Q3 | $108M | Buy |
419,798
+27,066
| +7% | +$6.96M | 0.04% | 355 |
|
|
2023
Q2 | $112M | Buy |
392,732
+96,648
| +33% | +$27.5M | 0.04% | 352 |
|
|
2023
Q1 | $82.3M | Buy |
296,084
+1,809
| +0.6% | +$503K | 0.03% | 423 |
|
|
2022
Q4 | $81.5M | Buy |
294,275
+147,458
| +100% | +$40.8M | 0.03% | 425 |
|
|
2022
Q3 | $39.2M | Sell |
146,817
-132,493
| -47% | -$35.4M | 0.02% | 603 |
|
|
2022
Q2 | $57M | Sell |
279,310
-84,208
| -23% | -$17.2M | 0.02% | 498 |
|
|
2022
Q1 | $76.6M | Buy |
363,518
+1,406
| +0.4% | +$296K | 0.03% | 456 |
|
|
2021
Q4 | $86.9M | Buy |
362,112
+48,149
| +15% | +$11.6M | 0.02% | 469 |
|
|
2021
Q3 | $88.8M | Buy |
313,963
+74,754
| +31% | +$21.2M | 0.03% | 446 |
|
|
2021
Q2 | $82.8M | Buy |
239,209
+40,143
| +20% | +$13.9M | 0.03% | 456 |
|
|
2021
Q1 | $55.7M | Sell |
199,066
-34,199
| -15% | -$9.57M | 0.02% | 573 |
|
|
2020
Q4 | $57.1M | Buy |
233,265
+97,735
| +72% | +$23.9M | 0.02% | 541 |
|
|
2020
Q3 | $38.4M | Sell |
135,530
-180,410
| -57% | -$51.2M | 0.01% | 615 |
|
|
2020
Q2 | $84.5M | Buy |
315,940
+52,443
| +20% | +$14M | 0.04% | 330 |
|
|
2020
Q1 | $83.4M | Sell |
263,497
-6,502
| -2% | -$2.06M | 0.04% | 310 |
|
|
2019
Q4 | $80.1M | Sell |
269,999
-118,267
| -30% | -$35.1M | 0.03% | 414 |
|
|
2019
Q3 | $90.4M | Buy |
388,266
+53,176
| +16% | +$12.4M | 0.03% | 351 |
|
|
2019
Q2 | $78.4M | Sell |
335,090
-15,209
| -4% | -$3.56M | 0.03% | 391 |
|
|
2019
Q1 | $82.8M | Buy |
350,299
+149,084
| +74% | +$35.2M | 0.03% | 365 |
|
|
2018
Q4 | $60.5M | Sell |
201,215
-170,596
| -46% | -$51.3M | 0.03% | 401 |
|
|
2018
Q3 | $131M | Buy |
371,811
+50,901
| +16% | +$18M | 0.05% | 266 |
|
|
2018
Q2 | $93.1M | Sell |
320,910
-36,357
| -10% | -$10.6M | 0.04% | 329 |
|
|
2018
Q1 | $97.8M | Sell |
357,267
-84,362
| -19% | -$23.1M | 0.04% | 304 |
|
|
2017
Q4 | $141M | Buy |
441,629
+242,120
| +121% | +$77.1M | 0.06% | 235 |
|
|
2017
Q3 | $62.5M | Sell |
199,509
-86,808
| -30% | -$27.2M | 0.03% | 396 |
|
|
2017
Q2 | $77.7M | Buy |
286,317
+111,258
| +64% | +$30.2M | 0.04% | 328 |
|
|
2017
Q1 | $47.9M | Buy |
175,059
+932
| +0.5% | +$255K | 0.03% | 449 |
|
|
2016
Q4 | $49.4M | Sell |
174,127
-142,594
| -45% | -$40.4M | 0.03% | 422 |
|
|
2016
Q3 | $99.1M | Buy |
316,721
+57,960
| +22% | +$18.1M | 0.06% | 263 |
|
|
2016
Q2 | $62.6M | Buy |
258,761
+9,013
| +4% | +$2.18M | 0.04% | 334 |
|
|
2016
Q1 | $65M | Sell |
249,748
-235,101
| -48% | -$61.2M | 0.04% | 329 |
|
|
2015
Q4 | $149M | Buy |
484,849
+284,807
| +142% | +$87.3M | 0.1% | 195 |
|
|
2015
Q3 | $58.4M | Buy |
200,042
+56,857
| +40% | +$16.6M | 0.04% | 356 |
|
|
2015
Q2 | $57.8M | Buy |
143,185
+3,827
| +3% | +$1.55M | 0.04% | 385 |
|
|
2015
Q1 | $58.8M | Sell |
139,358
-9,607
| -6% | -$4.06M | 0.04% | 380 |
|
|
2014
Q4 | $50.6M | Buy |
+148,965
| New | +$50.6M | 0.04% | 431 |
|